What is MRPC?
Established in 1921, MRPC has evolved into a premier single-source provider of innovative medical device components and assemblies. The company distinguishes itself through specialized cleanroom molding capabilities, including advanced silicone molding, two-material molding, and micro-molding. With ISO 13485 certification, MRPC maintains a rigorous commitment to quality and regulatory compliance, serving as a foundational pillar for clients navigating the complexities of the modern medical device landscape. Its century-long operational history provides a unique competitive advantage in manufacturing reliability and technical expertise.
How much funding has MRPC raised?
MRPC has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in MRPC
PPP
Public-Private Partnership
What's next for MRPC?
With the recent capital injection, MRPC is well-positioned to accelerate its operational scaling and enhance its manufacturing infrastructure. The strategic focus will likely center on expanding its micro-molding capacity and deepening its integration within the supply chains of high-growth medical technology firms. As the industry shifts toward more complex, miniaturized device architectures, MRPC's ability to provide end-to-end assembly solutions will be pivotal in maintaining its market leadership. This financial backing serves as a catalyst for further innovation, ensuring the firm remains at the forefront of medical component manufacturing for the next generation of healthcare solutions.
See full MRPC company page
